PocketLaw | CFR 21 | General Labeling Provisions

General Labeling Provisions

Checkout our iOS App for a better way to browser and research.

Drugs; name and place of business of manufacturer, packer, or distributor.

Drugs and devices; National Drug Code numbers.

Drugs; adequate directions for use.

Drugs; misleading statements.

Drugs; statement of ingredients.

Drugs; prominence of required label statements.

Drugs; Spanish-language version of certain required statements.

Drugs; location of expiration date.

Drugs; significance of control numbers.

Drugs; use of term “infant”.

Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use.

Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.

Prescription drugs containing sulfites; required warning statements.

Required pediatric studies.

Labeling for systemic antibacterial drug products.

Bar code label requirements.

Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile.